2015
DOI: 10.1016/j.jcms.2014.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Clonality analysis in primary oral squamous cell carcinoma and related lymph-node metastasis revealed by TP53 and mitochondrial DNA next generation sequencing analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 18 publications
(7 citation statements)
references
References 31 publications
0
7
0
Order By: Relevance
“…1). For patients with multiple primary carcinomas, the local recurrence rate was 14.8% (8/54): 1.9% (1/54) for synchronous first multiple primary carcinomas, 25.9% (14/54) for metachronous second multiple primary carcinomas and 9.3% (5/54) for metachronous third multiple primary carcinomas.…”
Section: Resultsmentioning
confidence: 99%
“…1). For patients with multiple primary carcinomas, the local recurrence rate was 14.8% (8/54): 1.9% (1/54) for synchronous first multiple primary carcinomas, 25.9% (14/54) for metachronous second multiple primary carcinomas and 9.3% (5/54) for metachronous third multiple primary carcinomas.…”
Section: Resultsmentioning
confidence: 99%
“…[ 19 ] However, the different biological growth patterns of malignancies mean that the identification of and socio-demographic and clinicopathological risk factors is still of utmost importance for predicting mortality. [ 20 , 21 ] However, data on socio-demographic and clinicopathological characteristics of patients with OSCC are still rare and therefore, for clarification, need to be obtained for a larger numbers of patients. [ 22 ] Therefore, the present retrospective, single-center study investigated the importance of socio-demographic and clinicopathological parameters that influence the mortality rate of the patients suffering from OSCC in the Kelantanse population.…”
Section: Introductionmentioning
confidence: 99%
“…In fact, our group could demonstrate the involvement of mtDNA mutations in several types of cancer [ 11 , 12 , 13 , 14 ]. Several studies reported a potential role of mtDNA mutations in OSCC [ 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 ]. The majority, however, suffered from limitations such as low sensitivity Sanger sequencing on a very small part of the mtDNA genome, like the D-Loop that undermined the original claims.…”
Section: Introductionmentioning
confidence: 99%